However, several reports have shown that conventional and real-time PCR assays were very specific for SARS CoV but lack sensitivity depending on the assay, specimen, and time course of disease.
Assaying specimens from other reservoirs (e.g., genital secretions, urine, plasma) may have demonstrated a difference between the two groups.
For all assays, specimens were obtained from female patients under fifty years of age, from the flank and thigh subcutaneous regions only.
MKP-1 was expressed in histologically normal colon epithelial cells and the pattern and intensity of staining were similar in all assayed specimens.
To determine the specificity of the two RT-PCR assays, specimens from both 35 bone marrow and 35 peripheral blood normal donors were evaluated.
The results showed that, using the multiplex assay, 192 specimens tested positive for FluA, including 35 specimens that were positive for the H7N9 virus.
These include the collection, handling and assay of specimens and the design of laboratories to routinely and reliably detect low levels of nucleic acid sequences.
Conclusion: The stringent and longitudinal use of an expanded HCMV UL97 RFLP assay of specimens from different sites contributes to the rapid and reliable diagnosis of GCV resistance.
In addition to designing an assay, collecting specimens for validation, and completing the validation, they must also design and implement a quality system to ensure continued performance of the assay.
To increase the stringency of assay evaluations, specimens with substantial numbers of polymorphisms in primer binding sites were included.
